Abstract
Pancreatic cancer is the fifth leading cause of cancer death in the United States, with an overall survival rate of 3%. Unfortunately, only a minority of patients present with localized disease amenable to surgical resection. Over the past 20 years, improvements in operative and perioperative management have led to a decrease in operative mortality, shorter hospital stay, and overall 5-year survival of approximately 20% in patients undergoing pancreaticoduodenectomy. Despite advances in nonoperative palliation, surgery continues to play an important role in the management of patients with locally advanced, unresectable pancreatic cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 725-734; discussion 734, 736-738, 740, 743 |
Journal | Oncology (Williston Park, N.Y.) |
Volume | 16 |
Issue number | 6 |
State | Published - Jun 2002 |
Externally published | Yes |
ASJC Scopus subject areas
- Oncology
- Cancer Research